Literature DB >> 25031767

Features of intraventricular tanycytic ependymoma: report of a case and review of literature.

Shweta Agarwal1, Michael E Stevenson1, Michael E Sughrue2, Eric P Wartchow3, Gary W Mierau3, Kar-Ming Fung4.   

Abstract

Tanycytic ependymoma is the rarest variant of ependymoma and occurs primarily in the spinal cord. Intracranial cases are even rarer. Only 9 ventricular and 5 subcortical tanycytic ependymoma have been reported in the literature. Amongst the 9 ventricular cases, only one tumor arose from the third ventricle. We report here another case of tanycytic ependymoma arising from the third ventricle completed with immunohistochemical, ultrastructural, and molecular pathology study. The patient was a 44 year-old male who presented with headache, nausea and visual disturbances of a few months duration. Neuroradiological findings showed a well-defined mass arising from the posterolateral wall of third ventricle. Histologically the tumor was composed of monotonous spindle cells arranged in fascicles without definitive perivascular rosettes. The tumor cells were diffusely positive for glial fibrillary acidic protein and epithelial membrane antigen, showed faint immunoreactivity for synaptophysin but were negative for neurofilament proteins and Ki-67 was less than 1%. Molecular studies showed absence of isocitrate dehydrogenase gene 1 and 2 mutation. A diagnosis of tanycytic ependymoma (TE) was made. From literature review with our current case included, intraventricular tanycytic ependymomas ranged from 1.8 to 4.0 cm. The age of patients ranged from 3.5 to 75 years with a mean age of 37.5 and a male predominance. The tumors occurred as well-defined, solitary ventricular mass without significant peritumoral edema with or without cystic changes. Histopathology and immunohistochemical profile are rather similar among different tumors. The immediate to short term outcome is excellent but long term follow up data is lacking.

Entities:  

Keywords:  Ventricular tumor; astrocytoma; ependymoma; subependymoma; tanycytic ependymoma

Mesh:

Substances:

Year:  2014        PMID: 25031767      PMCID: PMC4097299     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

1.  The tanycytic ependymoma of the lateral ventricle: case report.

Authors:  M Daneyemez; C Can; Y Izci; A Beduk; E Timuckaynak
Journal:  Minim Invasive Neurosurg       Date:  1999-12

2.  A case of tanycytic ependymoma arising from the cerebral hemisphere.

Authors:  Tamio Ito; Yoshimaru Ozaki; Hirohiko Nakamura; Shinya Tanaka; Kazuo Nagashima
Journal:  Brain Tumor Pathol       Date:  2006-10       Impact factor: 3.298

3.  Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas.

Authors:  S Suzuki; H Oka; N Kawano; S Tanaka; S Utsuki; K Fujii
Journal:  Brain Tumor Pathol       Date:  2001       Impact factor: 3.298

4.  Supratentorial ependymomas in adult patients.

Authors:  T H Schwartz; S Kim; R S Glick; E Bagiella; C Balmaceda; M R Fetell; B M Stein; M B Sisti; J N Bruce
Journal:  Neurosurgery       Date:  1999-04       Impact factor: 4.654

Review 5.  Intraventricular tanycytic ependymoma: case report and review of the literature.

Authors:  Brian T Ragel; Jeannette J Townsend; Adam S Arthur; William T Couldwell
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

6.  A 40-year-old male with an intraventricular tumor. Combined tanycytic ependymoma and subependymoma.

Authors:  Leonidas D Arvanitis; Paolo Gattuso; Sukriti Nag
Journal:  Brain Pathol       Date:  2013-05       Impact factor: 6.508

7.  Tanycytomas: a newly characterized hypothalamic-suprasellar and ventricular tumor.

Authors:  K A Lieberman; J J Wasenko; R Schelper; A Swarnkar; J K Chang; G S Rodziewicz
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

8.  The cytogenetic basis for classifying ependymomas.

Authors:  R L Friede; A Pollak
Journal:  J Neuropathol Exp Neurol       Date:  1978 Mar-Apr       Impact factor: 3.685

Review 9.  Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.

Authors:  Zachary J Reitman; Hai Yan
Journal:  J Natl Cancer Inst       Date:  2010-05-31       Impact factor: 11.816

10.  Tanycytic ependymoma: a challenging histological diagnosis.

Authors:  Khaled M Krisht; Meic H Schmidt
Journal:  Case Rep Neurol Med       Date:  2013-02-14
View more
  4 in total

1.  The clinical features and surgical outcomes of intracranial tanycytic ependymomas: a single-institutional experience.

Authors:  Xiaogang Tao; Jinqian Dong; Zonggang Hou; Shuyu Hao; Qi Zhang; Zhen Wu; Junting Zhang; Baiyun Liu
Journal:  J Neurooncol       Date:  2017-06-26       Impact factor: 4.130

2.  Chordoid Glioma with Intraventricular Dissemination: A Case Report with Perfusion MR Imaging Features.

Authors:  So Yeon Ki; Seul Kee Kim; Tae Wook Heo; Byung Hyun Baek; Hyung Seok Kim; Woong Yoon
Journal:  Korean J Radiol       Date:  2016-01-06       Impact factor: 3.500

Review 3.  Cerebellar ependymoma with overlapping features of clear-cell and tanycytic variants mimicking hemangioblastoma: a case report and literature review.

Authors:  Xiu-Peng Zhang; Yang Liu; Di Zhang; Qin Zheng; Chen Wang; Liang Wang; Qing-Chang Li; Xue-Shan Qiu; En-Hua Wang
Journal:  Diagn Pathol       Date:  2017-03-20       Impact factor: 2.644

4.  Tanycytic ependymoma of filum terminale: Clinical characteristics and surgical outcomes.

Authors:  Zonggang Hou; Xiaogang Tao; Junting Zhang; Zhen Wu; Baiyun Liu
Journal:  Oncol Lett       Date:  2018-10-01       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.